Compounds of formula (I):
wherein R2, W, A, Y, and R1 are as defined in the specification, and pharmaceutically acceptable salts thereof, are p38 MAPK inhibitors, and are useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.
式(I)化合物:其中R2、W、A、Y和R1如规范中所定义,并且其药学上可接受的盐,是p38
MAPK
抑制剂,可用于治疗呼吸道疾病等疾病的抗炎剂。